CN105682640A - 用于治疗下背痛的含有抗菌剂的生物可吸收的组合物 - Google Patents

用于治疗下背痛的含有抗菌剂的生物可吸收的组合物 Download PDF

Info

Publication number
CN105682640A
CN105682640A CN201480057751.5A CN201480057751A CN105682640A CN 105682640 A CN105682640 A CN 105682640A CN 201480057751 A CN201480057751 A CN 201480057751A CN 105682640 A CN105682640 A CN 105682640A
Authority
CN
China
Prior art keywords
weight
compositions
salt
contained
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480057751.5A
Other languages
English (en)
Chinese (zh)
Inventor
达维德·科瑞玛斯蔻理
卡洛·卢卡·罗曼诺
恩佐·米尼
埃德加多·科瑞玛斯蔻理
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novagenit Srl
Mero Srl
Original Assignee
Novagenit Srl
Mero Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novagenit Srl, Mero Srl filed Critical Novagenit Srl
Publication of CN105682640A publication Critical patent/CN105682640A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201480057751.5A 2013-10-21 2014-10-20 用于治疗下背痛的含有抗菌剂的生物可吸收的组合物 Pending CN105682640A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2013A001755 2013-10-21
IT001755A ITMI20131755A1 (it) 2013-10-21 2013-10-21 Composizione bioriassorbibile contenente agenti antibatterici per il trattamento del dolore lombare
PCT/IB2014/065471 WO2015059623A1 (en) 2013-10-21 2014-10-20 A bioreabsorbable composition containing antibacterial agents for the treatment of lower back pain

Publications (1)

Publication Number Publication Date
CN105682640A true CN105682640A (zh) 2016-06-15

Family

ID=49640024

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480057751.5A Pending CN105682640A (zh) 2013-10-21 2014-10-20 用于治疗下背痛的含有抗菌剂的生物可吸收的组合物

Country Status (7)

Country Link
JP (1) JP2016533354A (it)
CN (1) CN105682640A (it)
AU (1) AU2014338592A1 (it)
CA (1) CA2925690A1 (it)
IL (1) IL245164A0 (it)
IT (1) ITMI20131755A1 (it)
WO (1) WO2015059623A1 (it)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109982729A (zh) * 2016-11-16 2019-07-05 佩尔西卡制药有限公司 用于下背疼痛的抗生素制剂
CN111432800A (zh) * 2017-11-16 2020-07-17 佩尔西卡制药有限公司 利奈唑胺制剂
WO2021147635A1 (zh) * 2020-01-20 2021-07-29 山东威高药业股份有限公司 内镜微创手术用的填充组合物及填充制剂

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
WO2017065245A1 (ja) * 2015-10-13 2017-04-20 学校法人 慶應義塾 椎間板変性症、腰痛改善を処置するための医薬組成物、及び治療薬のスクリーニング方法
RU2737380C2 (ru) * 2017-04-24 2020-11-27 Общество с ограниченной ответственностью "ФБК" Комбинированное средство для внутрисуставного введения
WO2020064844A1 (en) * 2018-09-26 2020-04-02 Ascendis Pharma A/S Treatment of infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05970A (ja) * 1991-06-25 1993-01-08 Sumitomo Cement Co Ltd 骨ずい炎治療剤
WO2007050744A2 (en) * 2005-10-26 2007-05-03 Biocure, Inc. Hydrogel spinal disc implants with swellable articles
EP2213315A1 (en) * 2009-01-30 2010-08-04 Mero S.r.L. Antibacterial hydrogel and use thereof in orthopedics
WO2011082390A2 (en) * 2010-01-02 2011-07-07 Yeung Jeffrey E Internal and external disc shunts alleviate back pain
IT1401498B1 (it) * 2010-07-30 2013-07-26 Mero Srl Idrogelo a base di acido ialuronico e suo uso in ortopedia

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109982729A (zh) * 2016-11-16 2019-07-05 佩尔西卡制药有限公司 用于下背疼痛的抗生素制剂
CN109982729B (zh) * 2016-11-16 2022-04-22 佩尔西卡制药有限公司 用于下背疼痛的抗生素制剂
CN114712303A (zh) * 2016-11-16 2022-07-08 佩尔西卡制药有限公司 用于下背疼痛的抗生素制剂
CN111432800A (zh) * 2017-11-16 2020-07-17 佩尔西卡制药有限公司 利奈唑胺制剂
CN111432800B (zh) * 2017-11-16 2023-12-15 佩尔西卡制药有限公司 利奈唑胺制剂
WO2021147635A1 (zh) * 2020-01-20 2021-07-29 山东威高药业股份有限公司 内镜微创手术用的填充组合物及填充制剂

Also Published As

Publication number Publication date
JP2016533354A (ja) 2016-10-27
CA2925690A1 (en) 2015-04-30
WO2015059623A1 (en) 2015-04-30
ITMI20131755A1 (it) 2015-04-22
AU2014338592A1 (en) 2016-04-21
IL245164A0 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
CN105682640A (zh) 用于治疗下背痛的含有抗菌剂的生物可吸收的组合物
Wu et al. Biomimetic and osteogenic 3D silk fibroin composite scaffolds with nano MgO and mineralized hydroxyapatite for bone regeneration
Wang et al. Levofloxacin loaded mesoporous silica microspheres/nano-hydroxyapatite/polyurethane composite scaffold for the treatment of chronic osteomyelitis with bone defects
Vo et al. Injectable dual-gelling cell-laden composite hydrogels for bone tissue engineering
Fu et al. Injectable and thermo-sensitive PEG-PCL-PEG copolymer/collagen/n-HA hydrogel composite for guided bone regeneration
Tampieri et al. Magnetic bioinspired hybrid nanostructured collagen–hydroxyapatite scaffolds supporting cell proliferation and tuning regenerative process
Lee et al. Injectable biodegradable gelatin-methacrylate/β‐tricalcium phosphate composite for the repair of bone defects
Kim et al. Novel osteoinductive photo-cross-linkable chitosan-lactide-fibrinogen hydrogels enhance bone regeneration in critical size segmental bone defects
Parisi et al. Incorporation of collagen from marine sponges (spongin) into hydroxyapatite samples: characterization and in vitro biological evaluation
Munhoz et al. Use of collagen/chitosan sponges mineralized with hydroxyapatite for the repair of cranial defects in rats
Zhang et al. Efficacy of novel nano-hydroxyapatite/polyurethane composite scaffolds with silver phosphate particles in chronic osteomyelitis
JP6961629B2 (ja) 生体内分解率及び物性の調節が可能な生体適合性豚軟骨来由細胞外基質膜の製造方法
US11628069B2 (en) 3D printing of polymeric bioceramics for the treatment of bone defects
Pförringer et al. Osteoinduction and-conduction through absorbable bone substitute materials based on calcium sulfate: in vivo biological behavior in a rabbit model
Jayasuriya et al. Fabrication and characterization of novel hybrid organic/inorganic microparticles to apply in bone regeneration
US10076538B2 (en) Compositions comprising citrate and applications thereof
Cheng et al. Long-term antibacterial and biofilm dispersion activity of an injectable in situ crosslinked co-delivery hydrogel/microgel for treatment of implant infection
Wong et al. A systematic review on current osteosynthesis-associated infection animal fracture models
Ferreira-Ermita et al. Characterization and in vivo biocompatibility analysis of synthetic hydroxyapatite compounds associated with magnetite nanoparticles for a drug delivery system in osteomyelitis treatment
Kim et al. Osteochondral and bone tissue engineering scaffold prepared from Gallus var domesticus derived demineralized bone powder combined with gellan gum for medical application
JP2016504382A5 (it)
Zhang et al. Robust bioactive protein-based screws with dual crosslinked network for internal bone fixation
Lin et al. Augmentation of osseous phenotypes in vivo with a synthetic peptide
Li et al. Biological evaluation of acellular bovine bone matrix treated with NaOH
Zhang et al. Immobilization of RGD peptide onto the surface of apatite-wollastonite ceramic for enhanced osteoblast adhesion and bone regeneration

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160615